News
Lori Harvey enjoyed a stroll in Los Angeles, California with Sol de Janeiro’s Cheirosa 39 Perfume Mist in hand. The model ...
The latest price target for Nektar Therapeutics (NASDAQ:NKTR) was reported by HC Wainwright & Co. on June 24, 2025. The analyst firm set a price target for $120.00 expecting NKTR to rise to within ...
Explore Nektar Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for NKTR.
Nektar has said it will cut 70% of its workforce in the wake of the comprehensive failure in trials of its immuno-oncology candidate bempegaldesleukin, which was discontinued last week. The move ...
Nektar Therapeutics is waiting on multiple data readouts for its lead drug bempegaldesleukin paired with strategic partner Bristol-Myers Squibb’s checkpoint inhibitor Opdivo, but that hasn’t ...
Naomi Lim is a White House reporter at the Washington Examiner. She previously reported on crime and politics for News Corp Australia. She returned to Washington in 2015 after interning in ...
Naomi Elkins appeared virtually in Ocean County court before Judge Scott Basen Wednesday afternoon, from the county jail's ...
- Cboe Global Markets has introduced new spot Bitcoin ETF BuyWrite indices. - The BXGBTCA index generated 25.3% annualized returns with reduced volatility. - Covered call strategies aim to provide ...
Mike Belshe, CEO of BitGo, which serves as a custodian for two of 21Shares’ US Spot ETFs: the ARK 21Shares bitcoin ETF (ARKB) and the 21Shares Core ethereum ETF (CETH), joins Morning Brief with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results